Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic model identification of ribosome biogenesis-related genes in pancreatic cancer based on multiple machine learning analyses

24 May 2025

Abstract excerpt

BACKGROUND: Pancreatic cancer is a highly aggressive cancer characterized by low survival rate. Enhanced ribosome biogenesis may be associated with tumor drug resistance and malignant phenotypes, representing a potential therapeutic target in pancreatic cancer. Therefore, exploring the molecular mechanisms of ribosome biogenesis in pancreatic cancer may uncover new biomarkers and potential therapeutic targets,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Pancreatic and Hepatic Oncology Research
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40411705
DOI: 10.1007/s12672-025-02733-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic model identification of ribosome biogenesis-related genes in pancreatic cancer based on multiple machine learning analysesPMID 40411705Read ↗

Prognostic Model Identification of Ribosome Biogenesis-Related Genes in Pancreatic Cancer Based on Multiple Machine Learning AnalysesSemantic proximity Read ↗

Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic CancerSemantic proximity Read ↗

A transcriptomics-based meta-analysis combined with machine learning approach identifies a secretory biomarker panel for diagnosis of pancreatic adenocarcinomaSemantic proximity Read ↗

In Silico RNA-Seq Analysis Reveals Key Transcriptomic Signatures in Pancreatic CancerSemantic proximity Read ↗

Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinomaSemantic proximity Read ↗

Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic cancerSemantic proximity Read ↗

Development of a four-gene prognostic model for pancreatic cancer based on transcriptome dysregulationSemantic proximity Read ↗

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signalingSemantic proximity Read ↗

Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factorsSemantic proximity Read ↗

A novel aging-associated lncRNA prognostic signature for predicting immunotherapy and chemotherapy response in pancreatic cancerSemantic proximity Read ↗

Exploring ribosome biogenesis in lung adenocarcinoma to advance prognostic methods and immunotherapy strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.